Synuclein-γ suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1347-1352

  Liang, Bo ^a   Wang, Xin Jun ^a   Shen, Pei Hong ^a   Li, Xue Yuan ^a   Cheng, Hong Wei ^b   Shan, Qiao ^a   Guo, Kui Yuan ^a   Cao, Yu Wen ^a   Fan, Qing Xia ^c   Zheng, Rui Feng ^d   Li, Bei ^a   Zhang, Wei ^a   Yan Wei, L ^a   Yang, Kai ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d Henan People's Armed Police Corps Hospital   (China)

Author keywords

Breast cancer; MCF 7 cell line; RNA interference; Synuclein

Indexed keywords

GAMMA SYNUCLEIN; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL INVASION; CLONOGENESIS; CLONOGENIC ASSAY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84874434026     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1192     Document Type: Article

References (33)

1. Coughlin SS and Ekwueme DU: Breast cancer as a global health concern. Cancer Epidemiol 33: 315-318, 2009.
2. Garnock-Jones KP, Keating GM and Scott LJ: Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs 70: 215-239, 2010.
3. Lavedan C, Leroy E, Dehejia A, et al: Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet 103: 106-112,1998.
4. Surgucheva I, Weisman AD, Goldberg JL, et al: γ-Synuclein as a marker of retinal ganglion cells. Mol Vis 14: 1540-1548, 2008.
5. George JM: The synucleins. Genome Biol 3: REVIEWS3002, 2002.
6. Ahmad M, Attoub S, Singh MN, et al: Gamma-synuclein and the progression of cancer. FASEB 21: 3419-3430, 2007.
7. Shen PH, Fan QX, Li YW, et al: SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice. Chinese Med J (Engl) 124:1524-1528, 2011.
8. Lavedan C: The synuclein family. Genome Res 8: 871-880, 1998.
9. Von Bohlen and Halbach O: Synucleins and their relationship to Parkinson's disease. Cell Tissue Res 318: 163-174, 2004.
10. Iwai A: Properties of NACP/alpha-synuclein and its role in Alzheimer's disease. Biochim Biophys Acta 1502: 95-109, 2000.
11. Ji H, Liu Y, Jia T, et al: Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57: 759-764, 1997.
12. Bruening W, Giasson BI, Klein-Szanto AJ, et al: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163, 2000.
13. Zhao W, Liu H, Liu W, et al: Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int J Oncol 28: 1081-1088, 2006.
14. Zhou CQ, Liu S, Xue LY, et al: Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1900-1903, 2003.
15. Liu H, Liu W, Wu Y, et al: Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643, 2005.
16. Singh VK and Jia Z: Targeting synuclein-gamma to counteract drug resistance in cancer. Expert Opin Ther Targets 12: 59-68, 2008.
17. Liu J, Spence MJ, Zhang LY, et al: Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Res Treat 62: 99-107, 2002.
18. Lu A, Zhang F, Gupta A and Liu L: Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells. J Biol Chem 277: 31364-31372, 2002.
19. Jiang Y, Liu Y, Goldberg ID and Shi YE: Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Res 64: 4539-4546, 2004.
20. Jiang Y, Liu Y, Lu A, et al: Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 63: 3899-3903, 2003.
21. Ashihara E, Kawata E and Maekawa T: Future prospect of RNA interference for cancer therapies. Curr Drug Targets 11: 345-360, 2010.
22. Krajewska M, Krajewski S, Epstein JI, et al: Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148: 1567-1576, 1996.
23. Guo J, Shou C, Meng L, et al: Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer 121: 1296-1305, 2007.
24. Jia T, Liu YE, Liu J and Shi YE: Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 59: 742-747, 1999.
25. Gupta A, Inaba S, Wong OK, et al: Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593-7599,2003.
26. Inaba S, Li C, Shi YE, et al: Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94: 25-35, 2005.
27. Singh VK, Zhou Y, Marsh JA, et al: Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res 67: 626-633, 2007.
28. Zhou Y, Inaba S and Liu J: Inhibition of synuclein-γ expression increases the sensitivity of breast cancer cells to paclitaxel treatment. Int J Oncol 29: 289-295, 2006.
29. Surgucheva IG, Sivak JM, Fini ME, et al: Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 410: 167-176, 2003.
30. Liu H, Liu W, Wu Y, et al: Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643, 2005.
31. Martin TA, Gomez K, Watkins G, et al: Expression of breast cancer specific gene-1 (BCSG-1/γ-synuclein) is associated with tumor grade but not with clinical outcome of patients with breast cancer. Oncol Rep 16: 207-212, 2006.
32. Wu K, Weng Z, Tao Q, et al: Stage specific expression of breast cancer specific gene γ-synuclein. Cancer Epidemiol Biomark Prev 12: 920-925, 2003.
33. Dang RL, Shen FH, Xia QA, et al: Expression of γ-synuclein protein in ovarian cancer. Mod Prev Med 36: 3551-3553, 2009.